Trump administration finalizes rule limiting PSLF loan forgiveness for certain nonprofit workers, sparking legal challenges over politicization of the program.
DaVita's Q3 earnings miss expectations, with lower dialysis treatments and higher costs, leading to narrowed guidance and stock decline.
Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier deal and intensifying the race for dominance in the lucrative obesity drug market.
Trump administration finalizes rule limiting PSLF loan forgiveness for certain nonprofit workers, sparking legal challenges over politicization of the program.
DaVita's Q3 earnings miss expectations, with lower dialysis treatments and higher costs, leading to narrowed guidance and stock decline.
Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier deal and intensifying the race for dominance in the lucrative obesity drug market.